Search research articles
Contact Us
Filters
Showing results (1121-1130 of 1,204) with videos related to
Page
of 121
Sort By:
Cancer Biology & Therapy
|
November 12, 2019
Botryllamide G is an ABCG2 inhibitor that improves lapatinib delivery in mouse brain
Jonathan D Strope, Cody J Peer, Tristan M Sissung, et al.
Journal of the American Heart Association
|
May 22, 2019
Association of a Home Monitoring Program With Interstage and Stage 2 Outcomes
Monique M Gardner, Laura Mercer-Rosa, Jennifer Faerber, et al.
Journal of the American Heart Association
|
October 29, 2021
Successful Reduction of Postoperative Chest Tube Duration and Length of Stay After Congenital Heart Surgery: A Multicenter Collaborative Improvement Project
Katherine E Bates, Chloe Connelly, Lara Khadr, et al.
Oncotarget
|
July 2, 2014
Icotinib antagonizes ABCG2-mediated multidrug resistance, but not the pemetrexed resistance mediated by thymidylate synthase and ABCG2
De-Shen Wang, Atish Patel, Suneet Shukla, et al.
Cell Metabolism
|
December 26, 2017
Inactivation of the Glucose-Dependent Insulinotropic Polypeptide Receptor Improves Outcomes following Experimental Myocardial Infarction
John R Ussher, Jonathan E Campbell, Erin E Mulvihill, et al.
Breast Cancer Research and Treatment
|
September 14, 2016
ANG1005 for breast cancer brain metastases: correlation between <sup>18</sup>F-FLT-PET after first cycle and MRI in response assessment
C C O'Sullivan, M Lindenberg, C Bryla, et al.
Environmental Science & Technology
|
August 15, 2014
Illustrating anticipatory life cycle assessment for emerging photovoltaic technologies
Ben A Wender, Rider W Foley, Valentina Prado-Lopez, et al.
The Lancet. Oncology
|
June 27, 2024
Assessment of endpoint definitions in curative-intent trials for mucosal head and neck squamous cell carcinomas: Head and Neck Cancer International Group consensus recommendations
Annette M Lim, Lachlan McDowell, Chris Hurt, et al.
Elife
|
December 7, 2022
Weakly migratory metastatic breast cancer cells activate fibroblasts via microvesicle-Tg2 to facilitate dissemination and metastasis
Samantha C Schwager, Katherine M Young, Lauren A Hapach, et al.
Clinical Pharmacology and Therapeutics
|
August 8, 2006
Association of enzyme and transporter genotypes with the pharmacokinetics of imatinib
Erin R Gardner, Herman Burger, Ron H van Schaik, et al.
Page
of 121
Search research articles
Search
Showing results (1121-1130 of 1,204) with videos related to
Sort By:
Page
of 121
Cancer Biology & Therapy
|
November 12, 2019
Botryllamide G is an ABCG2 inhibitor that improves lapatinib delivery in mouse brain
Jonathan D Strope, Cody J Peer, Tristan M Sissung, et al.
Journal of the American Heart Association
|
May 22, 2019
Association of a Home Monitoring Program With Interstage and Stage 2 Outcomes
Monique M Gardner, Laura Mercer-Rosa, Jennifer Faerber, et al.
Journal of the American Heart Association
|
October 29, 2021
Successful Reduction of Postoperative Chest Tube Duration and Length of Stay After Congenital Heart Surgery: A Multicenter Collaborative Improvement Project
Katherine E Bates, Chloe Connelly, Lara Khadr, et al.
Oncotarget
|
July 2, 2014
Icotinib antagonizes ABCG2-mediated multidrug resistance, but not the pemetrexed resistance mediated by thymidylate synthase and ABCG2
De-Shen Wang, Atish Patel, Suneet Shukla, et al.
Cell Metabolism
|
December 26, 2017
Inactivation of the Glucose-Dependent Insulinotropic Polypeptide Receptor Improves Outcomes following Experimental Myocardial Infarction
John R Ussher, Jonathan E Campbell, Erin E Mulvihill, et al.
Breast Cancer Research and Treatment
|
September 14, 2016
ANG1005 for breast cancer brain metastases: correlation between <sup>18</sup>F-FLT-PET after first cycle and MRI in response assessment
C C O'Sullivan, M Lindenberg, C Bryla, et al.
Environmental Science & Technology
|
August 15, 2014
Illustrating anticipatory life cycle assessment for emerging photovoltaic technologies
Ben A Wender, Rider W Foley, Valentina Prado-Lopez, et al.
The Lancet. Oncology
|
June 27, 2024
Assessment of endpoint definitions in curative-intent trials for mucosal head and neck squamous cell carcinomas: Head and Neck Cancer International Group consensus recommendations
Annette M Lim, Lachlan McDowell, Chris Hurt, et al.
Elife
|
December 7, 2022
Weakly migratory metastatic breast cancer cells activate fibroblasts via microvesicle-Tg2 to facilitate dissemination and metastasis
Samantha C Schwager, Katherine M Young, Lauren A Hapach, et al.
Clinical Pharmacology and Therapeutics
|
August 8, 2006
Association of enzyme and transporter genotypes with the pharmacokinetics of imatinib
Erin R Gardner, Herman Burger, Ron H van Schaik, et al.
Page
of 121